Literature DB >> 25809007

Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma.

Xiaowei Wang1,2,3, Tianyao Guo1,2,3, Fang Peng1,2,3, Ying Long1,2,3, Yun Mu1,2,3, Haiyan Yang1,2,3,4, Ningrong Ye5, Xuejun Li5, Xianquan Zhan1,2,3,6.   

Abstract

Nonfunctional pituitary adenoma (NFPA) is highly heterogeneous with different hormone-expressed subtypes in NFPA tissues including follicle-stimulating hormone (FSH) positive, luteinizing hormone-positive, FSH/luteinizing hormone-positive, and negative types. To analyze in-depth the variations in the proteomes among different NFPA subtypes for our long-term goal to clarify molecular mechanisms of NFPA and to detect tumor biomarker for personalized medicine practice, a reference map of proteome of a human FSH-expressed NFPA tissue was described here. 2DE and PDQuest image analysis were used to array each protein. MALDI-TOF PMF and human Swiss-Prot databases with MASCOT search were used to identify each protein. A good 2DE pattern with high level of between-gel reproducibility was attained with an average positional deviation 1.98 ± 0.75 mm in the IEF direction and 1.62 ± 0.68 mm in the SDS-PAGE direction. Approximately 1200 protein spots were 2DE-detected and 192 redundant proteins that were contained in 141 protein spots were PMF-identified, representing 107 nonredundant proteins. Those proteins were located in cytoplasm, nucleus, plasma membrane, extracellular space, and so on, and those functioned in transmembrane receptor, ion channel, transcription/translation regulator, transporter, enzyme, phosphatase, kinase, and so on. Several important pathway networks were characterized from those identified proteins with DAVID and Ingenuity Pathway Analysis systems, including gluconeogenesis and glycolysis, mitochondrial dysfunction, oxidative stress, cell-cycle alteration, MAPKsignaling system, immune response, TP53-signaling, VEGF-signaling, and inflammation signaling pathways. Those resulting data contribute to a functional profile of the proteome of a human FSH-positive NFPA tissue, and will serve as a reference for the heterogeneity analysis of NFPA proteomes.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Mass spectrometry; Nonfunctional pituitary adenoma; Proteomic heterogeneity; Reference map; Two-dimensional gel electrophoresis

Mesh:

Substances:

Year:  2015        PMID: 25809007     DOI: 10.1002/elps.201500006

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  11 in total

1.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

Review 2.  Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine.

Authors:  Siqi Wen; Chunling Li; Xianquan Zhan
Journal:  EPMA J       Date:  2022-02-17       Impact factor: 6.543

Review 3.  Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Authors:  Xianquan Zhan; Xiaowei Wang; Tingting Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-31       Impact factor: 5.555

Review 4.  Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas.

Authors:  Xianquan Zhan; Ying Long
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-10       Impact factor: 5.555

Review 5.  Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas.

Authors:  Na Li; Xianquan Zhan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

6.  Editorial: Molecular Network Study of Pituitary Adenomas.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-18       Impact factor: 5.555

7.  Editorial: Systems Biological Aspects of Pituitary Tumors.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-30       Impact factor: 5.555

8.  The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues.

Authors:  Xianquan Zhan; Tian Zhou; Na Li; Huanni Li
Journal:  Data Brief       Date:  2018-08-14

9.  DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling.

Authors:  Jie Feng; Jianpeng Wang; Qian Liu; Jiye Li; Qi Zhang; Zhengping Zhuang; Xiaohui Yao; Chunhui Liu; Yangfang Li; Lei Cao; Chuzhong Li; Lei Gong; Dan Li; Yazhuo Zhang; Hua Gao
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244

10.  TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.

Authors:  Ya Wang; Tingting Cheng; Miaolong Lu; Yun Mu; Biao Li; Xuejun Li; Xianquan Zhan
Journal:  EPMA J       Date:  2019-08-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.